201 related articles for article (PubMed ID: 28633038)
61. The molecular and cellular mechanisms of depression: a focus on reward circuitry.
Fox ME; Lobo MK
Mol Psychiatry; 2019 Dec; 24(12):1798-1815. PubMed ID: 30967681
[TBL] [Abstract][Full Text] [Related]
62. Uncovering the Genetic Architecture of Major Depression.
McIntosh AM; Sullivan PF; Lewis CM
Neuron; 2019 Apr; 102(1):91-103. PubMed ID: 30946830
[TBL] [Abstract][Full Text] [Related]
63. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment.
Fang H; Tu S; Sheng J; Shao A
J Cell Mol Med; 2019 Apr; 23(4):2324-2332. PubMed ID: 30734486
[TBL] [Abstract][Full Text] [Related]
64. Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease.
Bromberger JT; Epperson CN
Obstet Gynecol Clin North Am; 2018 Dec; 45(4):663-678. PubMed ID: 30401549
[TBL] [Abstract][Full Text] [Related]
65. Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.
Pierpont TM; Limper CB; Richards KL
Front Oncol; 2018; 8():163. PubMed ID: 29915719
[TBL] [Abstract][Full Text] [Related]
66. CAR T cell therapy for B-cell lymphomas.
Chavez JC; Locke FL
Best Pract Res Clin Haematol; 2018 Jun; 31(2):135-146. PubMed ID: 29909914
[TBL] [Abstract][Full Text] [Related]
67. A tale of two antibodies: obinutuzumab versus rituximab.
Freeman CL; Sehn LH
Br J Haematol; 2018 Jul; 182(1):29-45. PubMed ID: 29741753
[TBL] [Abstract][Full Text] [Related]
68. The Benzodiazepine Binding Sites of GABA
Sigel E; Ernst M
Trends Pharmacol Sci; 2018 Jul; 39(7):659-671. PubMed ID: 29716746
[TBL] [Abstract][Full Text] [Related]
69. [Allogeneic haematopoietic cell transplantation for diffuse large B cell lymphoma: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
Bull Cancer; 2017 Dec; 104(12S):S131-S135. PubMed ID: 29173980
[TBL] [Abstract][Full Text] [Related]
70. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Reddy A; Zhang J; Davis NS; Moffitt AB; Love CL; Waldrop A; Leppa S; Pasanen A; Meriranta L; Karjalainen-Lindsberg ML; Nørgaard P; Pedersen M; Gang AO; Høgdall E; Heavican TB; Lone W; Iqbal J; Qin Q; Li G; Kim SY; Healy J; Richards KL; Fedoriw Y; Bernal-Mizrachi L; Koff JL; Staton AD; Flowers CR; Paltiel O; Goldschmidt N; Calaminici M; Clear A; Gribben J; Nguyen E; Czader MB; Ondrejka SL; Collie A; Hsi ED; Tse E; Au-Yeung RKH; Kwong YL; Srivastava G; Choi WWL; Evens AM; Pilichowska M; Sengar M; Reddy N; Li S; Chadburn A; Gordon LI; Jaffe ES; Levy S; Rempel R; Tzeng T; Happ LE; Dave T; Rajagopalan D; Datta J; Dunson DB; Dave SS
Cell; 2017 Oct; 171(2):481-494.e15. PubMed ID: 28985567
[TBL] [Abstract][Full Text] [Related]
71. The role of 5-HT receptors in depression.
Yohn CN; Gergues MM; Samuels BA
Mol Brain; 2017 Jun; 10(1):28. PubMed ID: 28646910
[TBL] [Abstract][Full Text] [Related]
72. Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A; Jacobsen E
Am J Hematol; 2020 Mar; 95(3):316-327. PubMed ID: 31814159
[TBL] [Abstract][Full Text] [Related]
73. The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma.
Min GJ; Jeon YW; Kim TY; Kwag D; Kim BS; Lee J; Lee JH; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Cho SG
Sci Rep; 2023 Oct; 13(1):17496. PubMed ID: 37840059
[TBL] [Abstract][Full Text] [Related]
74. Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma.
Yang F; Shi H; Xu T; Liu R; Lei Y; Li R; Deng B; Wu T; Ke X; Hu K
Bone Marrow Transplant; 2023 Apr; 58(4):440-442. PubMed ID: 36550201
[No Abstract] [Full Text] [Related]
75. Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis.
Bilajac E; Mahmutović L; Lundstrom K; Glamočlija U; Šutković J; Sezer A; Hromić-Jahjefendić A
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298660
[TBL] [Abstract][Full Text] [Related]
76. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
77. Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation.
Jung J; Lee H; Suh YG; Eom HS; Lee E
J Korean Med Sci; 2021 Mar; 36(8):e55. PubMed ID: 33650334
[TBL] [Abstract][Full Text] [Related]
78. Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis.
Wang J; Duan X; Yang L; Liu X; Hao C; Dong H; Gu H; Tang H; Dong B; Zhang T; Gao G; Liang R
Cell Transplant; 2020; 29():963689720975397. PubMed ID: 33238731
[TBL] [Abstract][Full Text] [Related]
79. Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies.
Viardot A; Locatelli F; Stieglmaier J; Zaman F; Jabbour E
Ann Hematol; 2020 Oct; 99(10):2215-2229. PubMed ID: 32856140
[TBL] [Abstract][Full Text] [Related]
80. The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis.
Selberg L; Stadtherr P; Dietrich S; Tran TH; Luft T; Hegenbart U; Bondong A; Meissner J; Liebers N; Schmitt M; Ho AD; Müller-Tidow C; Dreger P
Bone Marrow Transplant; 2021 Jan; 56(1):30-37. PubMed ID: 32555407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
